Diabetes mellitus is a metabolic condition characterised by chronic hyperglycaemia, and type II diabetes is the most common type, accounting for 90% of cases globally. Hyperglycaemia is major complication of Diabetes mellitus. Postprandial hyperglycaemia is the most common distinctive of diabetes. Inhibition of carbohydrate hydrolysing enzymes including amylase and glucosidase may be useful method for lowering postprandial blood sugar levels. Alpha amylase and glucosidase inhibitors are the most approaching targets in the development of lead compounds for the treatment and management of diabetes. This type of inhibitors, used in clinical practise for the treatment of diabetes are known to be associated with gastrointestinal side effects. Therefore, we need to synthesize new compounds which have fewer side effects. In present study synthesized thirty quinazolinone compounds (PM1-PM30) were screened for their inhibitory effect on alpha amylase and alpha glucosidase enzymes. All synthesized compounds PM1 to PM 30, possess good inhibitory activity similar to that of approved drug Acarbose. Compounds PM20 PM7, PM28, PM29 are remarkable potent alpha amylase inhibitors and compounds PM30, PM28, PM29, PM4 are remarkable potent alpha glucosidase inhibitors. Therefore, these compounds are beneficial for management and treatment of diabetes disorder.
Cite this article:
Pratik G. Modh, Laxman J. Patel. In vitro screening on Alpha amylase and Alpha glucosidase inhibitory activities of some novel Quinazolinone derivatives. Research Journal of Pharmacy and Technology. 2022; 15(9):4226-9. doi: 10.52711/0974-360X.2022.00710
Pratik G. Modh, Laxman J. Patel. In vitro screening on Alpha amylase and Alpha glucosidase inhibitory activities of some novel Quinazolinone derivatives. Research Journal of Pharmacy and Technology. 2022; 15(9):4226-9. doi: 10.52711/0974-360X.2022.00710 Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-9-70
1. Kumari AJ. A Mechanistic Approach to Determination of Anti-diabetic activity of Calystegia sepium R.Br. Flowering plants in normal and Streptozotocin induced rats. Asian Journal of Research in Pharmaceutical Sciences. 2014; 4(2): 55-70.
2. Babaso VU, Shivaji PG. Synthesis and type- II anti-diabetic activity of Pyrrolidine-2-carbonitrile derived Ligands in SHR-STZ Animal model. Asian Journal of Research in Chemistry. 2018; 11(1): 159-165.
3. Bonagiri S, Vijaya K, Shobharani S. Estimation of Anti-Diabetic property of Holarrhena pubescens by In Vitro method using L6 rat Skeletal Muscle Cell Lines. Research Journal of Pharmacy and Technology. 2020; 13(12): 6238-6242.
4. Archana S et al. Preparation, Standardisation and Evaluation of Hypoglycaemic effect of Herbal Formulation containing five Ethnomedicinal plants in Alloxan-Induced Hyperglycemic Wistar Rats. Research Journal of Pharmacy and Technology. 2020; 13(12): 5987-5992.
5. Preeti T. Antidiabetic Potential of Amritarishta Prepared by Traditional and Modern Methods in Alloxan Induced Diabetic rats. Research Journal of Pharmacology and Pharmacodynamics. 2014; 6(3): 129-134.
6. Firoj AT, Harinath NM. In vitro screening of Anti-diabetic activity and Anti-inflammatory activity of leaves extract of Barleria gibsoni Dalz. Research Journal of Pharmacy and Technology. 2021; 14(3): 1289-1292.
7. Hepcy KD, Venkatesh P, Dinakar A. Anti-Diabetic Activity of Aqueous Extract of Leaves of Pavonia zeylanica in Rats. Research Journal of Pharmacy and Technology. 2009; 2(4): 789-792.
8. Chakrabarti R, Rajagopalan R. Diabetes and insulin resistance associated disorders: Disease and the therapy. Current Science. 2002; 83(12): 1533-1538.
9. Bhosale UP et al. In vitro multiplication in different species in banana. Asian Journal of Plant Science and Research. 2011; 1(3): 23-27.
10. Mary Helen PA, Jesvin Bency B. Inhibitory potential of Amaranthus viridis on α-amylase and glucose entrapment efficacy In vitro. Research Journal of Pharmacy and Technology. 2019; 12(5): 2089-2092.
11. Lakshman KD et al. Alpha-Glucosidase Inhibitory Activities of Wrightia tinctoria Roxb and Schrebera swietenoides Roxb Bark Extract. Research Journal of Pharmacology and Pharmacodynamics. 2011; 3(1): 22-24.
12. Subramanian R, Asmawi AZ, Sadikun A. In vitro α-glucosidase and α-amylase enzyme inhibitory effect of Andrographis Paniculata extract and andrographolide. Acta Biochemica Polonica. 2008; 55: 391-398.
13. Choudhury A et al. Character of a wheat amylase inhibitor preparation and effects on fasting human pancreaticobiliary secretions and hormones. Gastroenterology. 1996; 111: 1313-1320.
14. Kavitha S et al. In vitro alpha amylase and alpha glucosidase inhibition activity of crude ethanol extract of Cisus arnottian. Asian Journal of Plant Science and Research. 2012; 2(4): 550-553.
15. Boivin M et al. Effect of a purified amylase inhibitor on carbohydrate metabolism after a mixed meal in healthy humans. Mayo Clinic Proceedings. 1987; 62: 249-255.
16. Kumanan R et al. Anti-diabetic and some haematological effects of ethylacetate and n-butanol fractions of Ganoderma lucidum aqueous extract in alloxan-induced diabetic Wistar rat. International Journal of Pharmaceutics and Biomedical Research. 2010; 1(2): 69-72.
17. Bischcoff H. Pharmacology of alpha-glucosidase inhibition. European Journal of Clinical Investigation. 1994; 24(3): 3-10.
18. Patrick P et al. Acarbose improves glycemic control in overweight type 2 diabetic patients insufficiently treated with metformin. Diabetes Care. 2003; 26: 269-273.
19. Ganesh A et al. Synthesis of novel 3-[(dialkyl/aryl amino) methyl]-2-substituted-4(3H)-Quinazolinones and evaluation of their Anti-inflammatory activity. Asian Journal of Pharmaceutical and Clinical Research. 2017; 7(2): 60-62.
20. Kavitha K et al. Synthesis and Evaluation of Quinazolinone Derivatives. Asian Journal of Research in Chemistry. 2017; 10(4): 577-581.
21. Anas AA, Hany EK. Antidiabetic activity of terfeziaclaveryi; an In vitro and In vivo study. Biomedical and Pharmacology Journal. 2019; 12(2): 603-608.
22. Shruti S et al. Persimmon leaf (Diospyros kaki), a potent α-glucosidase inhibitor and antioxidant: Alleviation of postprandial hyperglycemia in normal and diabetic rats. Journal of Medicinal Plants Research. 2011; 5(9): 1652-1658.
23. Suganya G et al. In vitro antidiabetic, antioxidant and anti-inflammatory activity of Clitoriaternatea L. International Journal of Pharmacy and Pharmaceutical Science. 2017; 6: 342-347.
24. Kotowaroo MI et al. Screening of traditional antidiabetic medicinal plants of Mauritius for possible α-Amylase inhibitory effects in vitro. Phytotherapy Research. 2006; 20: 228-231.
25. Abirami N et al. Phytochemical investigation and in vitro evaluation of hypoglycemic potential of Grewiahirsuta. International Journal of Pharma and Bio Sciences. 2014; 5: 76-83.